Gabelli & Co Investment Advisers’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Other funds holding EXAS
PRS
PWMAG
IA
HNB
BC
Gabelli & Co Investment Advisers's EXAS Position: Q1 2026 in Review
Gabelli & Co Investment Advisers sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 232,200 shares — an estimated $23.6M sold.
Gabelli & Co Investment Advisers first reported a position in EXAS in Q4 2018 and held it in 5 quarters. The position peaked at $23.6M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- Gabelli & Co Investment Advisers reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- Gabelli & Co Investment Advisers sold 232,200 Exact Sciences shares in Q1 2026, an estimated $23.6M.
- Gabelli & Co Investment Advisers first reported a position in Exact Sciences in Q4 2018 and held it in 5 quarters.
- Gabelli & Co Investment Advisers's Exact Sciences position peaked at $23.6M in Q4 2025.
- 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on Gabelli & Co Investment Advisers's 13F filing for Q1 2026, filed 14 May 2026.